comparemela.com

Latest Breaking News On - Halsin partners - Page 6 : comparemela.com

Addex to Present at the Bio-Europe Spring 2022 and Maxim Group – 2022 Virtual Growth Conferences

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesTim dyerMike sinclairCompany annual report on formMaxim groupJanssen pharmaceuticals incSwiss exchangeBio europe springGrowth conferenceAddex therapeuticsJanssen pharmaceuticalsAmerican depositary sharesHalsin partnersForward looking statementsPrivate securities litigation reform actAnnual report

Addex Reports Full Year 2021 Financial Results and Provides Corporate Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomEurostars innosuisseRoger millsTim dyerMike sinclairCompany annual report on formTooth associationJanssen pharmaceuticalsJanssen pharmaceuticals incSwiss exchangeUnited kingdom internationalHoc announcement pursuantUpcoming milestonesFinancial statementsCall details

Addex to Present at the Virtual Sachs Associates 3rd Annual European HealthTech and 15th Annual European Life Sciences CEO Forums

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesTim dyerMike sinclairCompany annual report on formEuropean life sciencesJanssen pharmaceuticals incSwiss exchangeAnnual european life sciencesAddex therapeuticsJanssen pharmaceuticalsAmerican depositary sharesHalsin partnersForward looking statementsPrivate securities litigation reform actAnnual reportAddex therapeutic

Addex Reports Q3 2021 Financial Results and Provides Corporate Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesUnited kingdomEurostars innosuisseRoger millsTim dyerMike sinclairCompany annual report on formCantor fitzgeraldTooth associationJanssen pharmaceuticalsJanssen pharmaceuticals incSwiss exchangeHoc announcement pursuantUpcoming milestonesFinancial dataConsolidated interim financial statements

Addex Therapeutics Initiates Phase 2 Clinical Study with Dipraglurant in Blepharospasm

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesRoger millsTim dyerMike sinclairCompany annual report on formAddex therapeutics ltdJanssen pharmaceuticals incSwiss exchangeHoc announcement pursuantTherapeutics ltdChief medical officerChief executive officerAddex therapeuticsJanssen pharmaceuticalsAmerican depositary sharesHalsin partners

vimarsana © 2020. All Rights Reserved.